Skip to main content

Diabetes Device News

Diabetes Devices monitor and help to manage your blood sugar levels to try to stay within the target range, helping prevent complications of diabetes.

BGM    CGM     Injection Pens     Insulin Pumps      AID

DiabetesMine’s Innovation Summit shares updates on device connectivity, stigma research, the Bionic Pancreas, and more!
Integrated care, artificial pancreas, and personalized treatments – the goals of this innovative partnership.
The latest on Medtronic’s drive to close the loop!
Find out if you qualify for this cutting-edge trial.
"If you gave me a fully self-driving car today, I wouldn’t use it. It would take me many months before I could build the confidence. We can’t just give patients the...
Twitter summary: FDA Approves Animas Vibe, allowing display of Dexcom G4 Platinum CGM on Pump Screen; Shipments begin in January 2015 Nearly 20 months after its initial...
Josh Airth, a 17-year old with type 1 diabetes, recently participated in a clinical trial of the Medtronic 670G "hybrid-closed loop"system (insulin pump + Enlite 3 CGM...
Major A1c improvements, weight loss, and no injections!
How this initiative aims to bring actionable recommendations from overwhelming data.
How this two-week trial looks to bring the Libre technology to health care.
Twitter summary: On Jan 22, @Microsoft & @JDRF host “walking the #t1d tightrope – in the cloud” on @NightScoutProj & more On January 22, Microsoft and JDRF will...
Sleek design and a future meter + test strip subscription service – how this diabetes management solution hopes to stand out from the rest.
More flexible data viewing, customizable alarms, excellent Clarity analysis software, and why expectations are so high.
One of our favorite conferences of the year is the Children with Diabetes Friends for Life Conference in Orlando. It’s always heartwarming to see many young people with...
Bringing added convenience to blood glucose monitoring in smartphone-connected device.
While Dexcom shook up the diabetes world when it announced a notable partnership with Google , the company also shared several other very exciting future product updates...
US launch expected in 2017. 80% of trial participants still using it!
What can you learn about your health, your ancestry, and more?
The 338-patient, Dexcom-sponsored DIaMonD Study aims to find out.
Plus, turning our eyes to the future in 2016!